NCT00544596View on ClinicalTrials.gov

R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2013

Conditions

Extensive Stage Small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

R-(-)-gossypol acetic acid

Given orally

DRUG

cisplatin

Given IV

DRUG

etoposide

Given IV

Trial Locations (4)

53715

UW Health Oncology - 1 South Park, Madison

53792

University of Wisconsin Hospital and Clinics, Madison

54601

Gundersen Lutheran, La Crosse

57104

Sanford Cancer Center-Oncology Clinic, Sioux Falls

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00544596 - R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter